Can less be more? testing transfusion limits in ECMO
NCT ID NCT06560164
First seen Aug 14, 2026 · Last updated Aug 14, 2026
Summary
This trial asks whether a restrictive red blood cell transfusion strategy is as safe as a liberal one for adults on ECMO, a life-support machine for heart or lung failure. Patients will be randomly assigned to receive transfusions only when their hemoglobin drops to 7.0 g/dL (restrictive) or 9.0 g/dL (liberal). The main goal is to compare 90-day survival rates between the two groups.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Red blood cell transfusion
- What this could lead to
- If a restrictive transfusion strategy proves non-inferior, it could reduce transfusion-related risks and costs for ECMO patients, potentially improving outcomes.
- What could go wrong
- This is a non-inferiority trial, so it may show that restrictive transfusions are not as safe. Transfusions themselves carry risks, and the trial's results may not apply to all ECMO patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Amsterdam UMC, location AMC
RECRUITINGAmsterdam, North Holland, 1105 AZ, Netherlands
-
CHU Charleroi
RECRUITINGCharleroi, Hainaut, 6000, Belgium
-
Erasmus MC
RECRUITINGRotterdam, South Holland, 3015 GD, Netherlands
-
Hôpital Erasme
RECRUITINGBrussels, Brussels Capital, 1070, Belgium
-
KU Leuven, medical IC
RECRUITINGLeuven, Flemish Brabant, 3000, Belgium
-
KU Leuven, surgical IC
RECRUITINGLeuven, Flemish Brabant, 3000, Belgium
-
Karolinska Universtiy Hospital
RECRUITINGStockholm, Stockholm County, 171 76, Sweden
-
Leids Universitair Medisch Centrum (LUMC)
RECRUITINGLeiden, South Holland, 2333 ZA, Netherlands
-
Maastricht Universitair Medisch Centrum+ (MUMC+)
RECRUITINGMaastricht, Limburg, 6229 HX, Netherlands
-
MedUni Wien
RECRUITINGVienna, State of Vienna, 1090, Austria
-
Medisch Spectrum Twente (MST)
RECRUITINGEnschede, Drenthe, 7512 KZ, Netherlands
-
Radboudumc
NOT_YET_RECRUITINGNijmegen, Gelderland, 6525 GA, Netherlands
-
St. Antonius Ziekenhuis
RECRUITINGNieuwegein, Utrecht, 3435 CM, Netherlands
-
Universitair Medisch Centrum Groningen (UMCG)
RECRUITINGGroningen, Provincie Groningen, 9713 GZ, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple blood test trend may flag ICU patients at risk
- Rethinking anemia: does blood hemoglobin tell the whole story?
- A simple nutrient may shield Babies' brains from iron deficiency
- School health rooms and trained teachers: a new hope for Zambia's children?
- Can a pill replace EPO shots for anemia in kidney disease?
- Can a daily pill ease anemia in bone marrow disorders?